|
Doctors, Research, and Periodicals:
Clinical Trials/Medical Resources:
- Infinity Pharmaceuticals Initiates Phase I Clinical Trial of IPI-504 for Patients with Gastrointestinal Stromal Tumors (GIST).
- Glivec International Patient Assistance Program (GIPAP) can help defray the cost of Gleevec.
- Novartis (Gleevec) Patient Assistance Program also helps with the cost of obtaining Gleevec. 1-866-884-5906
- Pfizer Oncology's FIRSTresource program, can help defray the cost of accessing the newly approved drug, SUTENT.
- AMN107, under development by Novartis, which also makes Gleevec, is one of two "son of Gleevec" agents being pursued to treat patients who are refractory to Gleevec or who develop resistance.
Help Novartis Oncology collect information from doctors on the diagnosis and management of GIST via doctor participation in a GIST registry. A copy of a brochure about the GIST registry is available for you to print and then bring to your doctor by clicking here. - ASCO's information for people living with cancer. [Link]
- Just been diagnosed with a rare form of cancer? Please visit www.rarecancerconnection.com
|
Education/Research Resources:
 |
The Internet Guide to GIST Resources |
|
Click here to download this guide. It installs the information on your computer so that you have the information at your fingertips when ever you need it. Note: You may get a pop-up blocker, just allow the pop-ups. If you are asked to download ActiveX, you need to do that too. |
|
Tell a friend about this site.
